SCHEMBL23248535

SCHEMBL23248535

C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3NS(C)(=O)=O)n2)c(OC)cc1N(C)CCN1CCOCC1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.69
▸ ALK Q9UM73 6/20 0.64
▸ EML4 Q9HC35 5/20 0.64
▸ ERBB2 P04626 1/20 0.63
▸ INSR P06213 1/20 0.63
▸ ROS1 P08922 1/20 0.63
▸ FER P16591 1/20 0.63
▸ LTK P29376 1/20 0.63
▸ BLK P51451 1/20 0.63
▸ PTK2 Q05397 1/20 0.63
▸ BTK Q06187 1/20 0.63
▸ TNK2 Q07912 1/20 0.63
▸ ERBB4 Q15303 1/20 0.63
▸ SLK Q9H2G2 1/20 0.63
▸ MAPK3 P27361 1/20 0.59
▸ LRRK2 Q5S007 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27238033 0.94 EGFR (0.66) EGFRALKEML4ERBB2INSR
SCHEMBL30223094 0.94 EGFR (0.66) EGFRALKEML4ERBB2INSR
SCHEMBL30223472 0.94 EGFR (0.66) EGFRALKEML4ERBB2INSR
SCHEMBL23248572 0.94 EGFR (0.68) EGFRALKEML4ERBB2INSR
SCHEMBL27238037 0.94 EGFR (0.66) EGFRALKEML4ERBB2INSR
SCHEMBL23255650 0.89 EGFR (0.64) EGFRBTKMAPK3LRRK2
SCHEMBL29624087 0.88 EGFR (0.81) EGFRALKEML4ERBB2INSR
SCHEMBL22806866 0.88 EGFR (0.81) EGFRALKEML4ERBB2INSR
SCHEMBL30223156 0.88 EGFR (0.71) EGFRALKEML4ERBB2INSR
SCHEMBL27237964 0.88 EGFR (0.71) EGFRALKEML4ERBB2INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021075691-A1 PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT 한국화학연구원 2021-04-22 — — WO claimed
WO-2021075691-A1 PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT 한국화학연구원 2021-04-22 — — WO disclosed
WO-2021075691-A1 PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT 한국화학연구원 2021-04-22 — — WO disclosed
Send feedback